Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Medtronic
Fuji
Farmers Insurance
US Army
Cipla
Chinese Patent Office
UBS
Julphar

Generated: April 27, 2018

DrugPatentWatch Database Preview

Details for Patent: 9,387,191

« Back to Dashboard

Which drugs does patent 9,387,191 protect, and when does it expire?

Patent 9,387,191 protects AURYXIA and is included in one NDA.

This patent has twenty-four patent family members in eleven countries.
Summary for Patent: 9,387,191
Title:Ferric citrate dosage forms
Abstract: Disclosed herein are ferric citrate-containing tablets. In various embodiments, the tablets include ferric citrate formulations that meet certain dissolution, tableting and disintegration standards. In various aspects, the tablet formulations can include ferric citrate as the active ingredient and a binder. The formulations also can include a lubricant and/or a disintegrant (which, in some embodiments, can be the same as the binder).
Inventor(s): Le; Henry Trong (Englewood Cliffs, NJ)
Assignee: Keryx Biopharmaceuticals, Inc. (New York, NY)
Application Number:13/255,326
Patent Claim Types:
see list of patent claims
Composition; Dosage form;

Drugs Protected by US Patent 9,387,191

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Keryx Biopharms AURYXIA ferric citrate TABLET;ORAL 205874-001 Sep 5, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 9,387,191

PCT Information
PCT FiledJuly 21, 2010PCT Application Number:PCT/US2010/042788
PCT Publication Date:January 27, 2011PCT Publication Number: WO2011/011541

International Family Members for US Patent 9,387,191

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2010276242 ➤ Try a Free Trial
Brazil 112012001372 ➤ Try a Free Trial
Canada 2768656 ➤ Try a Free Trial
China 102573807 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
US Army
Cantor Fitzgerald
Johnson and Johnson
McKesson
Fish and Richardson
Citi
Accenture
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.